Iterative method for estimating the robust domains of attraction of non-linear systems: Application to cancer chemotherapy model with parametric uncertainties
暂无分享,去创建一个
[1] Andrey V. Savkin,et al. Application of optimal control theory to analysis of cancer chemotherapy regimens , 2002, Syst. Control. Lett..
[2] Mazen Alamir,et al. On Probabilistic Certification of Combined Cancer Therapies Using Strongly Uncertain Models , 2015, Journal of theoretical biology.
[3] Riccardo Scattolini,et al. A stabilizing model-based predictive control algorithm for nonlinear systems , 2001, Autom..
[4] Mazen Alamir,et al. Domain of attraction estimation of cancer chemotherapy model affected by state proportional uncertainty , 2016, 2016 European Control Conference (ECC).
[5] A. Radunskaya,et al. Mixed Immunotherapy and Chemotherapy of Tumors: Modeling, Applications and Biological Interpretations , 2022 .
[6] E. Gilbert,et al. Theory and computation of disturbance invariant sets for discrete-time linear systems , 1998 .
[7] Mirko Fiacchini. Convex Difference Inclusions for Systems Analysis and Design. Inclusiones Convexas para el Análisis y el Diseño. , 2013 .
[8] P. Hahnfeldt,et al. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.
[9] E K Afenya,et al. Some perspectives on modeling leukemia. , 1998, Mathematical biosciences.
[10] R. B. Martin,et al. Optimal control drug scheduling of cancer chemotherapy , 1992, Autom..
[11] Stephen P. Boyd,et al. Convex Optimization , 2004, Algorithms and Theory of Computation Handbook.
[12] G. Chesi. Domain of Attraction: Analysis and Control via SOS Programming , 2011 .
[13] A. Murugan,et al. Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls. , 2007, Mathematical biosciences.
[14] J. Aubin,et al. Differential inclusions set-valued maps and viability theory , 1984 .
[15] E. F. Camacho,et al. On the computation of convex robust control invariant sets for nonlinear systems , 2010, Autom..
[16] Ami Radunskaya,et al. A mathematical tumor model with immune resistance and drug therapy: an optimal control approach , 2001 .
[17] David Q. Mayne,et al. Invariant approximations of the minimal robust positively Invariant set , 2005, IEEE Transactions on Automatic Control.
[18] Franco Blanchini,et al. Set-theoretic methods in control , 2007 .
[19] T. Alamo,et al. Convex invariant sets for discrete-time Lur'e systems , 2009, Autom..
[20] 丸山 徹. Convex Analysisの二,三の進展について , 1977 .
[21] J. M. Murray,et al. Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle. , 1994, Mathematical biosciences.
[22] Mazen Alamir,et al. Robust feedback design for combined therapy of cancer , 2014 .
[23] E. Afenya,et al. Acute leukemia and chemotherapy: a modeling viewpoint. , 1996, Mathematical biosciences.
[24] Jean-Pierre Aubin,et al. Viability theory , 1991 .
[25] D. Bertsekas. Infinite time reachability of state-space regions by using feedback control , 1972 .
[26] Panos M. Pardalos,et al. Convex optimization theory , 2010, Optim. Methods Softw..
[27] K. T. Tan,et al. Linear systems with state and control constraints: the theory and application of maximal output admissible sets , 1991 .
[28] Mazen Alamir,et al. Invariance-based analysis of cancer chemotherapy , 2015, 2015 IEEE Conference on Control Applications (CCA).
[29] Eduardo F. Camacho,et al. Invariant sets computation for convex difference inclusions systems , 2012, Syst. Control. Lett..
[30] G. W. Swan. Role of optimal control theory in cancer chemotherapy. , 1990, Mathematical biosciences.
[31] S Chareyron,et al. Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes. , 2009, Journal of theoretical biology.
[32] Urszula Ledzewicz,et al. Optimal control for combination therapy in cancer , 2008, 2008 47th IEEE Conference on Decision and Control.